In Partnership With:
Health economics and outcomes research (HEOR) has become essential for pharmaceutical, biotech, and medical device product development and commercialization. HEOR provides critical evidence on the multiple dimensions of product value, including clinical, economic, and societal value, as well as value for patients, decision makers, and healthcare policy. EpidStrategies scientists work with clients across the spectrum to design, execute, and analyze scientifically rigorous and commercially relevant health economics and outcomes research. Our HEOR studies quantify the value of new and existing therapies for key stakeholders, including payers, providers, patients, and policy makers. Our scientists disseminate HEOR findings in presentations at well-recognized health policy and academic congresses (e.g., ISPOR, ISPOR EU, ICPE, AMCP, ASHEcon), at multiple clinical conferences (e.g., AMCP, ANA, AAN, ASH, AHA, DDW, IDWeek, ICPE, ISHLT, IAS), and in the peer-reviewed literature.
Core Services
- Characterize demographics, clinical characteristics, treatment patterns, outcomes, healthcare resource utilization, and costs for patients with specific disease conditions
- Estimate burden of illness from payer, patient, caregiver, and societal perspectives
- Calculate incidence and prevalence of specific disease conditions, including rare diseases
- Identify, manage, and analyze real-world data sets (e.g., primary data, electronic health records, Medicare, Medicaid, commercial claims data), chart reviews, and surveys
- Guide and implement patient-reported outcomes (PRO) instrument selection to measure and evaluate general and disease-specific health and functional status, quality of life, and health-related quality of life
- Develop economic models to quantify the value of new and existing therapies
- Conduct targeted literature reviews and data landscape assessments
Evaluate existing evidence and evidence gaps, and develop recommendations to address those gaps